Literature DB >> 18264724

Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer.

M Schrauder1, S Frank, P L Strissel, M P Lux, M R Bani, C Rauh, C C Sieber, K Heusinger, A Hartmann, R Schulz-Wendtland, R Strick, M W Beckmann, Peter A Fasching.   

Abstract

PURPOSE: Various ATM (ataxia telangiectasia-mutated) mutations and polymorphisms have been reported to be associated with an increased breast cancer risk. Recent studies have produced contradictory results regarding the association between ATM genetic variants and breast cancer risk.
MATERIALS AND METHODS: The common ATM polymorphism 5557G>A (p.D1853N) (rs1801516), previously suggested to be associated with bilateral breast cancer, was analyzed using real-time PCR in 514 unselected patients with breast cancer and 511 age-matched healthy control individuals. DNA was obtained from peripheral blood draw.
RESULTS: The ATM genotype was weakly associated with the risk for breast cancer (P = 0.04 for the overall test). The odds ratio for women with a heterozygous genotype was 0.70 (95% CI, 0.52-0.94) and for the homozygous variant 0.63 (95% CI, 0.27-1.49). Disease-free survival and overall survival showed no significant association with specific genotypes.
CONCLUSIONS: The results of this study might suggest a minor association between polymorphism 5557G>A and a reduced risk of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18264724     DOI: 10.1007/s00432-008-0355-9

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  34 in total

1.  Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia.

Authors:  A L Børresen; T I Andersen; S Tretli; A Heiberg; P Møller
Journal:  Genes Chromosomes Cancer       Date:  1990-11       Impact factor: 5.006

Review 2.  Initiating cellular stress responses.

Authors:  Christopher J Bakkenist; Michael B Kastan
Journal:  Cell       Date:  2004-07-09       Impact factor: 41.582

3.  Assessing the probability that a positive report is false: an approach for molecular epidemiology studies.

Authors:  Sholom Wacholder; Stephen Chanock; Montserrat Garcia-Closas; Laure El Ghormli; Nathaniel Rothman
Journal:  J Natl Cancer Inst       Date:  2004-03-17       Impact factor: 13.506

4.  Genomic Organization of the ATM gene.

Authors:  T Uziel; K Savitsky; M Platzer; Y Ziv; T Helbitz; M Nehls; T Boehm; A Rosenthal; Y Shiloh; G Rotman
Journal:  Genomics       Date:  1996-04-15       Impact factor: 5.736

Review 5.  Genomic instability and cancer: networks involved in response to DNA damage.

Authors:  Jorunn Erla Eyfjord; Sigridur Klara Bodvarsdottir
Journal:  Mutat Res       Date:  2005-07-05       Impact factor: 2.433

6.  ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.

Authors:  A Broeks; J H Urbanus; A N Floore; E C Dahler; J G Klijn; E J Rutgers; P Devilee; N S Russell; F E van Leeuwen; L J van 't Veer
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

7.  The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer.

Authors:  Denise L Stredrick; Montserrat Garcia-Closas; Marbin A Pineda; Parveen Bhatti; Bruce H Alexander; Michele M Doody; Jolanta Lissowska; Beata Peplonska; Louise A Brinton; Stephen J Chanock; Jeffery P Struewing; Alice J Sigurdson
Journal:  Hum Mutat       Date:  2006-06       Impact factor: 4.878

8.  Breast and other cancers in families with ataxia-telangiectasia.

Authors:  M Swift; P J Reitnauer; D Morrell; C L Chase
Journal:  N Engl J Med       Date:  1987-05-21       Impact factor: 91.245

9.  Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study.

Authors:  Kristjana Einarsdóttir; Lena U Rosenberg; Keith Humphreys; Carine Bonnard; Juni Palmgren; Yuqing Li; Yi Li; Kee S Chia; Edison T Liu; Per Hall; Jianjun Liu; Sara Wedrén
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

10.  Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia.

Authors:  J H Olsen; J M D Hahnemann; A-L Børresen-Dale; S Tretli; R Kleinerman; R Sankila; L Hammarström; T E Robsahm; H Kääriäinen; A Bregård; K Brøndum-Nielsen; J Yuen; M Tucker
Journal:  Br J Cancer       Date:  2005-07-25       Impact factor: 7.640

View more
  25 in total

1.  7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium.

Authors:  Roger L Milne; Justo Lorenzo-Bermejo; Barbara Burwinkel; Núria Malats; Jose Ignacio Arias; M Pilar Zamora; Javier Benítez; Manjeet K Humphreys; Montserrat García-Closas; Stephen J Chanock; Jolanta Lissowska; Mark E Sherman; Arto Mannermaa; Vesa Kataja; Veli-Matti Kosma; Heli Nevanlinna; Tuomas Heikkinen; Kristiina Aittomäki; Carl Blomqvist; Hoda Anton-Culver; Argyrios Ziogas; Peter Devilee; Christie J van Asperen; Rob A E M Tollenaar; Caroline Seynaeve; Per Hall; Kamila Czene; Jianjun Liu; Astrid K Irwanto; Daehee Kang; Keun-Young Yoo; Dong-Young Noh; Fergus J Couch; Janet E Olson; Xianshu Wang; Zachary Fredericksen; Børge G Nordestgaard; Stig E Bojesen; Henrik Flyger; Sara Margolin; Annika Lindblom; Peter A Fasching; Ruediger Schulz-Wendtland; Arif B Ekici; Matthias W Beckmann; Shan Wang-Gohrke; Chen-Yang Shen; Jyh-Cherng Yu; Huan-Ming Hsu; Pei-Ei Wu; Graham G Giles; Gianluca Severi; Laura Baglietto; Dallas R English; Angela Cox; Ian Brock; Graeme Elliott; Malcolm W R Reed; Jonathan Beesley; Xiaoqing Chen; Kconfab Investigators; Olivia Fletcher; Lorna Gibson; Isabel dos Santos Silva; Julian Peto; Bernd Frank; Joerg Heil; Alfons Meindl; Jenny Chang-Claude; Rebecca Hein; Alina Vrieling; Dieter Flesch-Janys; Melissa C Southey; Letitia Smith; Carmel Apicella; John L Hopper; Alison M Dunning; Karen A Pooley; Paul D P Pharoah; Ute Hamann; Beate Pesch; Yon-Dschun Ko; Douglas F Easton; Georgia Chenevix-Trench
Journal:  J Med Genet       Date:  2011-10       Impact factor: 6.318

2.  Association between ATM 5557G>A polymorphism and breast cancer risk: a meta-analysis.

Authors:  Chen Mao; Vincent C H Chung; Ben-Fu He; Rong-Cheng Luo; Jin-Ling Tang
Journal:  Mol Biol Rep       Date:  2011-05-21       Impact factor: 2.316

3.  Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study.

Authors:  Gerard Lozanski; Amy S Ruppert; Nyla A Heerema; Arletta Lozanski; David M Lucas; Amber Gordon; John G Gribben; Vicki A Morrison; Kanti M Rai; Guido Marcucci; Richard A Larson; John C Byrd
Journal:  Leuk Lymphoma       Date:  2012-06-02

4.  Risk Factors for Endometriosis in a German Case-Control Study.

Authors:  S Burghaus; P Klingsiek; P A Fasching; A Engel; L Häberle; P L Strissel; M Schmidt; K Jonas; J D Strehl; A Hartmann; J Lermann; A Boosz; F C Thiel; A Müller; M W Beckmann; S P Renner
Journal:  Geburtshilfe Frauenheilkd       Date:  2011-12       Impact factor: 2.915

5.  Percent Mammographic Density and Dense Area as Risk Factors for Breast Cancer.

Authors:  C Rauh; C C Hack; L Häberle; A Hein; A Engel; M G Schrauder; P A Fasching; S M Jud; A B Ekici; C R Loehberg; M Meier-Meitinger; S Ozan; R Schulz-Wendtland; M Uder; A Hartmann; D L Wachter; M W Beckmann; K Heusinger
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-08       Impact factor: 2.915

6.  CYP2B6*6 is associated with increased breast cancer risk.

Authors:  Christina Justenhoven; Daniela Pentimalli; Sylvia Rabstein; Volker Harth; Anne Lotz; Beate Pesch; Thomas Brüning; Thilo Dörk; Peter Schürmann; Natalia Bogdanova; Tjoung-Won Park-Simon; Fergus J Couch; Janet E Olson; Peter A Fasching; Matthias W Beckmann; Lothar Häberle; Arif Ekici; Per Hall; Kamilla Czene; Janjun Liu; Jingmei Li; Christian Baisch; Ute Hamann; Yon-Dschun Ko; Hiltrud Brauch
Journal:  Int J Cancer       Date:  2013-07-30       Impact factor: 7.396

7.  Molecular defects in Moroccan patients with ataxia-telangiectasia.

Authors:  L Jeddane; F Ailal; C Dubois-d'Enghien; O Abidi; I Benhsaien; A Kili; S Chaouki; Y Kriouile; N El Hafidi; H Fadil; R Abilkassem; N Rada; A A Bousfiha; A Barakat; D Stoppa-Lyonnet; H Bellaoui
Journal:  Neuromolecular Med       Date:  2013-01-16       Impact factor: 3.843

8.  11q13 is a susceptibility locus for hormone receptor positive breast cancer.

Authors:  Diether Lambrechts; Therese Truong; Christina Justenhoven; Manjeet K Humphreys; Jean Wang; John L Hopper; Gillian S Dite; Carmel Apicella; Melissa C Southey; Marjanka K Schmidt; Annegien Broeks; Sten Cornelissen; Richard van Hien; Elinor Sawyer; Ian Tomlinson; Michael Kerin; Nicola Miller; Roger L Milne; M Pilar Zamora; José Ignacio Arias Pérez; Javier Benítez; Ute Hamann; Yon-Dschun Ko; Thomas Brüning; Jenny Chang-Claude; Ursel Eilber; Rebecca Hein; Stefan Nickels; Dieter Flesch-Janys; Shan Wang-Gohrke; Esther M John; Alexander Miron; Robert Winqvist; Katri Pylkäs; Arja Jukkola-Vuorinen; Mervi Grip; Georgia Chenevix-Trench; Jonathan Beesley; Xiaoqing Chen; Florence Menegaux; Emilie Cordina-Duverger; Chen-Yang Shen; Jyh-Cherng Yu; Pei-Ei Wu; Ming-Feng Hou; Irene L Andrulis; Teresa Selander; Gord Glendon; Anna Marie Mulligan; Hoda Anton-Culver; Argyrios Ziogas; Kenneth R Muir; Artitaya Lophatananon; Suthee Rattanamongkongul; Puttisak Puttawibul; Michael Jones; Nicholas Orr; Alan Ashworth; Anthony Swerdlow; Gianluca Severi; Laura Baglietto; Graham Giles; Melissa Southey; Federik Marmé; Andreas Schneeweiss; Christof Sohn; Barbara Burwinkel; Betul T Yesilyurt; Patrick Neven; Robert Paridaens; Hans Wildiers; Hermann Brenner; Heiko Müller; Volker Arndt; Christa Stegmaier; Alfons Meindl; Sarah Schott; Claus R Bartram; Rita K Schmutzler; Angela Cox; Ian W Brock; Graeme Elliott; Simon S Cross; Peter A Fasching; Ruediger Schulz-Wendtland; Arif B Ekici; Matthias W Beckmann; Olivia Fletcher; Nichola Johnson; Isabel Dos Santos Silva; Julian Peto; Heli Nevanlinna; Taru A Muranen; Kristiina Aittomäki; Carl Blomqvist; Thilo Dörk; Peter Schürmann; Michael Bremer; Peter Hillemanns; Natalia V Bogdanova; Natalia N Antonenkova; Yuri I Rogov; Johann H Karstens; Elza Khusnutdinova; Marina Bermisheva; Darya Prokofieva; Shamil Gancev; Anna Jakubowska; Jan Lubinski; Katarzyna Jaworska; Katarzyna Durda; Børge G Nordestgaard; Stig E Bojesen; Charlotte Lanng; Arto Mannermaa; Vesa Kataja; Veli-Matti Kosma; Jaana M Hartikainen; Paolo Radice; Paolo Peterlongo; Siranoush Manoukian; Loris Bernard; Fergus J Couch; Janet E Olson; Xianshu Wang; Zachary Fredericksen; Grethe Grenaker Alnaes; Vessela Kristensen; Anne-Lise Børresen-Dale; Peter Devilee; Robert A E M Tollenaar; Caroline M Seynaeve; Maartje J Hooning; Montserrat García-Closas; Stephen J Chanock; Jolanta Lissowska; Mark E Sherman; Per Hall; Jianjun Liu; Kamila Czene; Daehee Kang; Keun-Young Yoo; Dong-Young Noh; Annika Lindblom; Sara Margolin; Alison M Dunning; Paul D P Pharoah; Douglas F Easton; Pascal Guénel; Hiltrud Brauch
Journal:  Hum Mutat       Date:  2012-04-30       Impact factor: 4.878

9.  Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival.

Authors:  Elizabeth M Azzato; Jonathan Tyrer; Peter A Fasching; Matthias W Beckmann; Arif B Ekici; Rüdiger Schulz-Wendtland; Stig E Bojesen; Børge G Nordestgaard; Henrik Flyger; Roger L Milne; José Ignacio Arias; Primitiva Menéndez; Javier Benítez; Jenny Chang-Claude; Rebecca Hein; Shan Wang-Gohrke; Heli Nevanlinna; Tuomas Heikkinen; Kristiina Aittomäki; Carl Blomqvist; Sara Margolin; Arto Mannermaa; Veli-Matti Kosma; Vesa Kataja; Jonathan Beesley; Xiaoqing Chen; Georgia Chenevix-Trench; Fergus J Couch; Janet E Olson; Zachary S Fredericksen; Xianshu Wang; Graham G Giles; Gianluca Severi; Laura Baglietto; Melissa C Southey; Peter Devilee; Rob A E M Tollenaar; Caroline Seynaeve; Montserrat García-Closas; Jolanta Lissowska; Mark E Sherman; Kelly L Bolton; Per Hall; Kamila Czene; Angela Cox; Ian W Brock; Graeme C Elliott; Malcolm W R Reed; David Greenberg; Hoda Anton-Culver; Argyrios Ziogas; Manjeet Humphreys; Douglas F Easton; Neil E Caporaso; Paul D P Pharoah
Journal:  J Natl Cancer Inst       Date:  2010-03-22       Impact factor: 13.506

10.  The UGT1A6_19_GG genotype is a breast cancer risk factor.

Authors:  Christina Justenhoven; Ofure Obazee; Stefan Winter; Sylvia Rabstein; Anne Lotz; Volker Harth; Beate Pesch; Thomas Brüning; Christian Baisch; Jaana M Hartikainen; Arto Mannermaa; Veli-Matti Kosma; Vesa Kataja; Robert Winqvist; Katri Pylkäs; Arja Jukkola-Vuorinen; Mervi Grip; Peter A Fasching; Matthias Beckmann; Arif B Ekici; Alexander Hein; Per Hall; Jingmei Li; Jenny Chang-Claude; Dieter Flesch-Janys; Petra Seibold; Anja Rudolph; Ute Hamann; Yon-Dschun Ko; Hiltrud Brauch
Journal:  Front Genet       Date:  2013-06-11       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.